Clinical Studies
Overview
Epiretinal beta radiation therapy is approved for the treatment of wet age-related macular degeneration (AMD) in the European Union; in the United States it is an investigational treatment at this time, and is being studied in several clinical trials, including CABERNET. Follow the links to learn more about each of these unique studies.